本页面由Tiger Trade Technology Pte. Ltd.提供服务

XILIO THERAPEUTICS, INC.

0.7322
+0.00220.30%
盘后0.73220.00000.00%19:50 EST
成交量:47.46万
成交额:34.64万
市值:3,844.07万
市盈率:-0.65
高:0.7400
开:0.7276
低:0.7061
收:0.7300
52周最高:1.70
52周最低:0.6150
股本:5,250.03万
流通股本:2,343.38万
量比:0.57
换手率:2.03%
股息:- -
股息率:- -
每股收益(TTM):-1.1285
每股收益(LYR):-1.0884
净资产收益率:-908.28%
总资产收益率:-26.26%
市净率:-4.75
市盈率(LYR):-0.67

数据加载中...

2024/04/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/10

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/10

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/09/05

重要事件披露

Form 8-K - Current report